Overview
Updated 14 Jul 2026
Nancy E. Kemeny, MD, is Emeritus Member, Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine (retired September 2023 after 45+ years on staff) at Memorial Sloan Kettering Cancer Center. The public record shows 612 publications with 37,022 citations (h-index 99), centered on Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies, Cholangiocarcinoma and Gallbladder Cancer Studies. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 3 companies, 2 NIH-funded awards (1987–2001).
- Most recent indexed publication: 2025 · JCO precision oncology
- Top research focus: Hepatocellular Carcinoma Treatment and Prognosis
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 299.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
InvestigatorPhase 2CompletedNCT03693807 - Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
InvestigatorPhase 2CompletedNCT01312857 - Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
InvestigatorPhase 1CompletedNCT00695201
Industry payments
Updated 14 Jul 2026
3 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20251 payment
- Intera Oncology, IncProgram year20246 payments
- Amgen Inc.Program year20241 payment
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 1987–2001 per NIH RePORTER. The latest:
- THERAPY OF HEPATIC METASTASES FROM COLORECTAL CARCINOMA
Sloan-Kettering Institute for Cancer Res
FY2001$115,989R01CA061524 - THERAPY OF HEPATIC METASTASES FROM COLORECTAL CARCINOMA
Sloan-Kettering Institute for Cancer Res
FY2000$142,553R01CA061524 - THERAPY OF HEPATIC METASTASES FROM COLORECTAL CARCINOMA
Sloan-Kettering Institute for Cancer Res
FY1999R01CA061524
Congress activity
Updated 14 Jul 2026
65 congress contributions (2004–2024) across AACR, ASCO per OpenAlex. The most recent:
- Intrahepatic cholangiocarcinoma: Recurrence patterns, genomics and survival.
ASCO Annual Meeting
ASCO2024Co-author - Salvage hepatic artery infusion chemotherapy after first-line systemic failure in patients with unresectable cholangiocarcinoma.
ASCO Annual Meeting
ASCO2024Co-author - Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
ASCO Annual Meeting
ASCO2023Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and Survival.
JCO precision oncology
2025 - A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier.
Clinical cancer research
2024
Most-cited worksby citation count (OpenAlex)
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD
University of Medicine and Dentistry of New Jersey (1971), one directory (Healthgrades) lists Seton Hall University instead; likely refers to the same institution's earlier name/lineage, unresolved
1971provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - BA
University of Pennsylvania
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Residency
Internal Medicine, St. Luke's-Roosevelt Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Fellowship
Internal Medicine/Oncology, Memorial Sloan Kettering Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Board Certified
Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sharecare.com ↗ - Board Certified
Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sharecare.com ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗
Secondary affiliationsappointments beyond the home institution
- Professor Emerita of Medicine
Weill Cornell Medical College (formerly Assistant/Associate/full Professor in the Department of Medicine at Cornell University/Weill Cornell during active career)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vivo.weill.cornell.edu ↗
Media & interviewspress, podcasts and appearances
- "Interview with an Icon: Dr. Nancy Kemeny on HAI Pumps"
video interview, ColonTown University / YouTube DocTalk
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →learn.colontown.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/nancy-kemeny-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Nancy-Kemeny-39306104
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/nancy-kemeny-2474b015
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
mskcc.cloud-cme.com/default.aspx
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.cloud-cme.com ↗ - X / Twitter
x.com/InteraOncology/status/1730634026719859108
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗ - LinkedIn
LinkedIn: "Professor at MSKCC" (nancy-kemeny-2474b015)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Van Cutsem, MD, PhD
Universitair Ziekenhuis Leuven
- 1,845
- publications
- 177
- h-index
- 14
- trials
Josep Tabernero, MD, PhD
Vall d'Hebron Institut de Recerca
- 2,704
- publications
- 148
- h-index
- 19
- trials
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
- 1,745
- publications
- 154
- h-index
- 22
- trials
Charles Fuchs, MD, MPH
Yale Cancer Center
- 1,721
- publications
- 172
- h-index
- 7
- trials